Sign in

CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company

ENDONOVO THERAPEUTICS, INC.

Sign in to watch
Ticker
ENDV
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452552528
Phone
(800) 489-4774
Business address
6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
Former names
Hanover Portfolio Acquisitions, Inc.
  1. 4 Open-market buy CEO bought 32,000 shares at an average $0.01 ($288)
  2. 4 Open-market buy CEO bought 114,000 shares at an average $0.01 ($1,113)
  3. 4 Open-market buy CEO bought 119,000 shares at an average $0.01 ($1,226)
  4. 4 Open-market buy CEO bought 55,000 shares at an average $0.01 ($597)
  5. 4 Open-market buy CEO bought 89,500 shares at an average $0.01 ($918)
  6. 10-Q Report Quarterly Report
  7. 4 Open-market buy CEO bought 62,000 shares at an average $0.01 ($698)
  8. 4 Open-market buy CEO bought 96,000 shares at an average $0.01 ($1,186)
  9. 4 Open-market buy CEO bought 59,700 shares at an average $0.02 ($921)
  10. 4 Open-market buy CEO bought 275,000 shares at an average $0.02 ($4,437)
  11. 4 Open-market buy CEO bought 75,000 shares at an average $0.02 ($1,211)
  12. 4 Open-market buy CEO bought 52,000 shares at an average $0.01 ($636)
  13. 8-K Event Other events
  14. 4 Open-market buy CEO bought 111,000 shares at an average $0.01 ($1,256)
  15. 4 Open-market buy CEO bought 34,000 shares at an average $0.01 ($425)
  16. 4 Open-market buy CEO bought 191,000 shares at an average $0.01 ($2,294)
  17. 4 Open-market buy CEO bought 490,500 shares at an average $0.01 ($5,180)
  18. 4 Open-market buy CEO bought 181,000 shares at an average $0.01 ($1,725)
  19. 4 Open-market buy CEO bought 374,200 shares at an average $0.01 ($3,797)
  20. 4 Open-market buy CEO bought 43,000 shares at an average $0.01 ($472)

Page 5 of 26 · 502 filings